Client Services: 201.528.9187

FHACT® takes the guess work out of cervical cancer screening

WATCH THE VIDEO >

Get answers, get FHACT®. Webinar Series.

LEARN MORE >

CGI delivers results for complex, B-Cell cancers

LEARN MORE >

CGI Expands Global Reach with Acquisition of Bioserve India

LEARN MORE >

Excellence in Oncology

Our comprehensive array of integrated laboratory services adds significant value to the process of diagnosing cancer.

We Have Answers

If you have been diagnosed with a non-Hodgkin lymphoma (NHL) or Kidney cancer, we have important information for you.

Complete Program

World-class and proprietary capabilities for the diagnosis and prognosis of CLL and DLBCL.

Latest News

  • 21 Oct 14

Cancer Genetics Inc. Granted Patent for Genomic Probe Set Used in Proprietary Test for Cervical and Other HPV-Associated Cancers

- > Issuance of patent 8,865,882 covers four probe set used in CGI's proprietary FISH-based HPV-Associated Cancer Test (FHACT®) > FHACT&(read more...)

CGI Reports

Client Access To Patient Reports

order_test
$7.83
CGIX +0.85
order_test